Skip to product information
1 of 4

SUCLA2 Rabbit Polyclonal Antibody

SUCLA2 Rabbit Polyclonal Antibody

Catalog Number: S0B60483 Application: WB Reactivity: Hu, Ms, Rt, Mk Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen SUCLA2
Synonyms Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial; ATP-specific succinyl-CoA synthetase subunit beta (A-SCS); Itaconyl--CoA ligase [ADP-forming] subunit beta (;); Malyl--CoA ligase [ADP-forming] subunit beta (;); Succinyl-CoA synthetase beta-A chain (SCS-betaA)
Immunogen Synthetic Peptide
Location Mitochondrion
Accession Q9P2R7
Antibody Type Polyclonal antibody
Isotype IgG
Application WB
Reactivity Hu, Ms, Rt, Mk
Positive Sample Caco-2, HeLa, HEK-293, MOLT-4, RAW264.7, PC-12, COS7
Predicted Reactivity Bv
Purification Immunogen Affinity
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu, Ms, Rt, Mk

Background

The SUCLA2 (succinyl-CoA ligase ADP-forming subunit beta) gene encodes the beta subunit of succinyl-CoA ligase, a key enzyme in the mitochondrial tricarboxylic acid (TCA) cycle that catalyzes the conversion of succinyl-CoA to succinate coupled with the phosphorylation of ADP to ATP. This enzyme functions as a heterodimer composed of an invariant alpha subunit (SUCLG1) and a substrate-specific beta subunit (SUCLA2 or SUCLG2), with the ADP-specific beta subunit encoded by SUCLA2 being predominantly expressed in high-energy-demanding tissues such as the brain and skeletal muscle. In addition to its direct involvement in energy metabolism, SUCLA2 also interacts with nucleoside diphosphate kinase and participates in maintaining mitochondrial DNA synthesis and stability. Pathogenic variants in this gene cause autosomal recessive SUCLA2-related mitochondrial DNA depletion syndrome, also known as mitochondrial DNA depletion syndrome type 5, characterized by early-onset encephalopathy, hypotonia, developmental delay, myopathy, movement disorders, sensorineural hearing loss, and elevated lactate and methylmalonic acid levels.

Picture

Western Blot

WB result of SUCLA2 Rabbit Polyclonal Antibody
Primary antibody: SUCLA2 Rabbit Polyclonal Antibody at 1/1000 dilution
Lane 1: Caco-2 whole cell lysate 20 µg
Lane 2: HeLa whole cell lysate 20 µg
Lane 3: HEK-293 whole cell lysate 20 µg
Lane 4: Hep G2 whole cell lysate 20 µg
Lane 5: MOLT-4 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 50 kDa
Observed MW: 40 kDa

WB result of SUCLA2 Rabbit Polyclonal Antibody
Primary antibody: SUCLA2 Rabbit Polyclonal Antibody at 1/1000 dilution
Lane 1: RAW 264.7 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 50 kDa
Observed MW: 40 kDa

WB result of SUCLA2 Rabbit Polyclonal Antibody
Primary antibody: SUCLA2 Rabbit Polyclonal Antibody at 1/1000 dilution
Lane 1: PC-12 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 50 kDa
Observed MW: 40 kDa

WB result of SUCLA2 Rabbit Polyclonal Antibody
Primary antibody: SUCLA2 Rabbit Polyclonal Antibody at 1/1000 dilution
Lane 1: COS7 whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 50 kDa
Observed MW: 40 kDa